Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

IBI-362 demonstrates body weight-lowering effect in phase I trial

Aug. 20, 2021

Joint venture announcement behind AR-035 and AR-882 development in China

Aug. 18, 2021

Crovalimab evaluated for vaso-occlusive episodes in patients with sickle cell disease

Aug. 17, 2021

BBP-631 enters phase I/II for treating congenital adrenal hyperplasia

Aug. 17, 2021

Moderna initiates phase I/II study of mRNA-3705 for methylmalonic acidemia

Aug. 17, 2021

FDA lifts clinical hold on trial of Danon disease treatment RP-A501

Aug. 16, 2021

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Aug. 13, 2021

lncRNA HULC linked to phenylketonuria prevention, HULC-mimetics show therapeutic promise

Aug. 13, 2021

Imatinib preserves Beta-cell function in subjects with type 1 diabetes

Aug. 12, 2021

FDA clears IND for XeriSol levothyroxine subcutaneous injection

Aug. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...